General
| Peptide: | BMAP-28 |
| Microorganism: | Enterococcus faecalis ATCC 29212 |
| Administration: | |
| Stage: | Formation (3-24h) |
| Notes: | ureteral stent |
Experimental procedure
| Method | AMP Effect(Biofilm reduction) | Concentration | Notes |
|---|---|---|---|
| Total countable CFUs | >= 1 log | 0.325 uM |
Reference
- Fiorenza Orlando, Roberto Ghiselli, Oscar Cirioni, Daniele Minardi, Linda Tomasinsig, Federico Mocchegiani, Carmela Silvestri, Barbara Skerlavaj, Alessandra Riva, Giovanni Muzzonigro, Vittorio Saba, Giorgio Scalise, Margherita Zanetti, Andrea Giacometti BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection
M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.
Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com